Exela Pharma Sciences recalls ibuprofen lysine injection vials

Tim Casey | | Cardiovascular Business | Interventional Cardiology

Exela Pharma Sciences, LLC voluntarily recalled a lot of its ibuprofen lysine injection vials after discovering some of the vials contained particulate matter.

The FDA announced the recall in a news release on Feb. 8.

Ibuprofen lysine injection is used to close a clinically significant patent ductus arteriosus in premature infants when medical management is ineffective.

Exela and marketer X-Gen Pharmaceuticals have received no adverse event reports related to the recall. However, the companies said that participate matter could block blood vessels, provoke an immune reaction and/or lead to potentially life threatening microinfarcts.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Related Content

Cardiologists reflect on developing primary PCI in face of criticism and pushback
How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
IVUS-guided PCI reduces risks in patients with diabetes
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
LAAC with Watchman FLX reduces bleeding risks after AFib ablation

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."